With Vodafone Global IoT SIM, Ekso Bionics manages device diagnostics and data to help improve the mobility of stroke and spinal cord injury patients.
Vodafone will be connecting the world’s first and only exoskeleton that is FDA cleared for use with both stroke patients and spinal cord injuries – the Ekso GT from Ekso Bionics. Vodafone’s network and global Internet of Things (IoT) SIM will ensure reliable communications for diagnostics and improved access to patient data, helping to improve the user experience with the suit.
Robotic exoskeletons are ready to wear, battery-powered robots that are strapped over the users’ clothing, enabling individuals to achieve mobility, strength or endurance not otherwise possible.
The Ekso GT can provide adaptive amounts of power to either side of the patient’s body, helping to improve results for patients. The suit allows physical therapists to mobilize patients earlier, more frequently and with a greater number of high intensity steps, all which will aid recovery.
Ekso Bionics has been able to simplify its manufacturing process by using the same Vodafone SIM for all suits globally as well as having a single worldwide partner delivering a managed service. Ekso Bionics’ Ekso GT is currently available in the United States, Mexico, Canada, South Africa, and in most European countries. The Ekso GT is offered in more than 150 leading rehabilitation institutions around the world and has helped enable its users to take more than 50 million steps not otherwise possible.
Vodafone
vodafone.com
Ekso Bionics
eksobionics.com
